Invention Grant
- Patent Title: Modulation of DYRK1B expression
-
Application No.: US16085140Application Date: 2017-03-16
-
Publication No.: US10577607B2Publication Date: 2020-03-03
- Inventor: Brett P. Monia , Shuling Guo , Susan F. Murray
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Grant IP
- International Application: PCT/US2017/022782 WO 20170316
- International Announcement: WO2017/161168 WO 20170921
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/7125 ; A61P3/04 ; A61K31/712 ; A61K31/7115 ; A61K9/00 ; A61K31/7088 ; A61K31/713 ; A61K45/06
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of DYRKIB in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease or disorder in an individual in need.
Public/Granted literature
- US20190071678A1 MODULATION OF DYRK1B EXPRESSION Public/Granted day:2019-03-07
Information query
IPC分类:
